Fact CheckerSign in

NCT06598670Completed

Transcranial Direct Current Stimulation on Post Stroke Depression

Effects of Transcranial Direct Current Stimulation on Post Stroke Depression

Source: ClinicalTrials.gov · Last updated 8 May 2026

Brief summary (registry, in English)

The aim of the research is to address the critical gap that limited number of RCTs are conducted on this topic. To further explore the efficacy of tDCs, large sample sizes, large follow up period and rigorously controlled randomized clinical trials are necessary. An optimum stimulation protocol is also needed on this study. Previous studies lack information regarding effects of this stimulation on depression, cognition, quality of life in relation to different severity levels of stroke.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
12 Sept 2024
Start date
25 Oct 2024
Primary completion date
31 Aug 2025
Lead sponsor
Riphah International University
Diseases
Stroke
NCT number
NCT06598670

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 25 Oct 2024 to the primary completion date, 31 Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Individual with any pacemaker and metal implant in body.

Other illness

  • Any medical condition like cardiac arrhythmias, uncontrolled hypertension.
  • Patient with any other neurological and psychiatric condition.

Who the study is looking for

  • Stroke for more than 6 months
  • Both gender with equal ratio on stroke severity basis
  • Depression diagnosed by Psychiatrist
  • Mild and moderate Depression at PHQ-9
  • National Institutes of Health Stroke Scale (NIHSS) for severity level; Mild (1-4), Moderate (5-15), Moderate to Severe (16-20), Severe (21-42)

Age in the registry: 25 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pakistan Railway General Hospital
Coordinator of this site? Confirm its status
RawalpindiPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.